New Englad Journal of Medicine | sciencenewsnet.in

Breaking News

Distinguished Lecture: Targeting a World-Leading Market Supplier of Graphene Materials

University of Idaho researcher uncovers surprising way to stop beer from exploding

Novel Pulmonary Valve Aims to Reduce Invasive Surgeries for Kids

When countries hide their true public debt, they hurt themselves, their citizens and their lenders

UTEP Team to Investigate Climate Change Impact on Pecan Orchards

Houston Methodist Tuberculosis expert Ed Graviss says U.S. experiencing its highest number of TB cases in 10 years

أوصى باحثو مايو كلينك ببدائل لاستئصال الرحم لعلاج الأورام الليفية في الرحم، وفقًا لدراسة

Ancient DNA Challenges Stories Told About Pompeii Victims

Designing battery success from failure

Physics with a twist: FSU researchers publish new findings on graphene

08 Nov, 2024

Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Reduces Hospitalizations and Improves Survival

March 5, 2023 sarah JonasResearch Results

Breakthrough findings from study led by Mount Sinai researcher could improve outcomes for high-risk patients

Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

July 14, 2022 sarah JonasResearch Results

A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the current standard of chemotherapy alone. Results of the research were presented by Stephen Ansell, M.D., Ph.D., at the 2022 American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago and were published today in the New England Journal of Medicine.